For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.

Compared to the people who got a placebo, those who received Ozempic said they drank fewer drinks at home. They also drank less in the lab at the trial’s end. A bonus: smokers smoked fewer cigarettes, too.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an unlikely source: a drug best known for treating diabetes and obesity. Semaglutide,